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In recent years Ionic Liquids (ILs) are being applied in life sciences. ILs are being 
produce with active pharmaceutical drugs (API) as they can reduce polymorphism 
and drug solubility problems [1] Also ILs are being applied as a drug delivery device 
in innovative therapies What is appealing in ILs is the ILs building up platform, the 
counter-ion can be carefully chosen in order to avoid undesirable side effects or to 
give innovative therapies in which two active ions are paired. 
This work shows ILs based on ampicillin (an anti-bacterial agent) and ILs based on 
Amphotericin B. Also we show studies that indicate that ILs based on Ampicillin 
could reverse resistance in some bacteria. 
The ILs produced in this work were synthetized by the neutralization method 
described in Ferraz et. al. [2] Ampicillin anion was combined with the following 
organic cations 1-ethyl-3-methylimidazolium, [EMIM]; 1-hydroxy-ethyl-3-
methylimidazolium, [C2OHMIM]; choline, [cholin]; tetraethylammonium, [TEA]; 
cetylpyridinium, [C16pyr] and trihexyltetradecylphosphonium, [P6,6,6,14]. 
Amphotericin B was combined with [C16pyr], [cholin] and 1-metohyethyl-3-
methylimidazolium, [C3OMIM]. The ILs-APIs based on ampicillin
[2] were tested 
against sensitive Gram-negative bacteria Escherichia coli ATCC 25922 and 
Klebsiella pneumonia (clinical isolated), as well as on Gram positive Staphylococcus 
Aureus ATCC 25923, Staphylococcus epidermidis and Enterococcus faecalis. The 
arising resistance developed by bacteria to antibiotics is a serious public health 
threat and needs new and urgent measures. We study the bacterial activity of these 
compounds against a panel of resistant bacteria (clinical isolated strains): E. coli 
CTX M9, E. coli TEM CTX M9, E. coli TEM1, E. coli CTX M2, E. coli AmpC Mox2. 
In this work we demonstrate that is possible to produce ILs from anti-bacterial and 
anti-fungal compounds. We show here that the new ILs can reverse the bacteria 
resistance. With the careful choice of the organic cation, it is possible to create 
important biological and physic-chemical properties. This work also shows that the 
ion-pair is fundamental in ampicillin mechanism of action. 
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